These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 17957910

  • 1. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V, Sangthawan M.
    J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study.
    Lamlertkittikul S, Chandeying V.
    J Med Assoc Thai; 2004 Jan; 87(1):33-40. PubMed ID: 14971532
    [Abstract] [Full Text] [Related]

  • 3. Challenges in the conduct of Thai herbal scientific study: efficacy and safety of phytoestrogen, pueraria mirifica (Kwao Keur Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women.
    Chandeying V, Lamlertkittikul S.
    J Med Assoc Thai; 2007 Jul; 90(7):1274-80. PubMed ID: 17710964
    [Abstract] [Full Text] [Related]

  • 4. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.
    Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S, Moghasemi M, Faghihzadeh S.
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [Abstract] [Full Text] [Related]

  • 6. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
    Cieraad D, Conradt C, Jesinger D, Bakowski M.
    Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
    [Abstract] [Full Text] [Related]

  • 7. Medroxyprogesterone and conjugated oestrogen are equivalent for hot flushes: a 1-year randomized double-blind trial following premenopausal ovariectomy.
    Prior JC, Nielsen JD, Hitchcock CL, Williams LA, Vigna YM, Dean CB.
    Clin Sci (Lond); 2007 May; 112(10):517-25. PubMed ID: 17419685
    [Abstract] [Full Text] [Related]

  • 8. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C.
    Maturitas; 2006 Feb 20; 53(3):252-9. PubMed ID: 15990257
    [Abstract] [Full Text] [Related]

  • 9. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Diaby V, Perreault S, Lachaine J.
    Maturitas; 2007 Oct 20; 58(2):138-49. PubMed ID: 17870259
    [Abstract] [Full Text] [Related]

  • 10. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA, Wang ST, Pai MC, Chen CH, Wu MH, Huang KE.
    J Reprod Med; 2003 May 20; 48(5):375-80. PubMed ID: 12815913
    [Abstract] [Full Text] [Related]

  • 11. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 12. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
    Taner MZ, Ozpolat E, Taskiran C, Onan MA, Gursel T, Karabulut E, Gursoy R, Himmetoglu O.
    Maturitas; 2006 Feb 20; 53(3):267-73. PubMed ID: 15978753
    [Abstract] [Full Text] [Related]

  • 13. Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.
    Inan I, Kelekci S, Yilmaz B.
    Gynecol Endocrinol; 2005 Feb 20; 20(2):64-7. PubMed ID: 15823823
    [Abstract] [Full Text] [Related]

  • 14. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct 20; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 15. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P.
    Arch Gynecol Obstet; 2006 Aug 20; 274(5):289-96. PubMed ID: 16810536
    [Abstract] [Full Text] [Related]

  • 16. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D, Yeşildaglar N, Erkaya S.
    Gynecol Endocrinol; 2005 Apr 20; 20(4):209-12. PubMed ID: 16019363
    [Abstract] [Full Text] [Related]

  • 17. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML, Evans GW, Riley W, McBride KH, Paskett ED, Helmond FA, Grobbee DE, OPAL Investigators.
    Eur Heart J; 2006 Mar 20; 27(6):746-55. PubMed ID: 16415304
    [Abstract] [Full Text] [Related]

  • 18. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Vacca F, Genazzani AR.
    Maturitas; 2005 Feb 14; 50(2):91-7. PubMed ID: 15653005
    [Abstract] [Full Text] [Related]

  • 19. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H, Al-Azzawi F, UK VR Multicentre Trial Group.
    BJOG; 2003 Aug 14; 110(8):753-9. PubMed ID: 12892687
    [Abstract] [Full Text] [Related]

  • 20. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.
    Woo J, Lau E, Ho SC, Cheng F, Chan C, Chan AS, Haines CJ, Chan TY, Li M, Sham A.
    Menopause; 2003 Aug 14; 10(4):352-61. PubMed ID: 12851519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.